ReviewJournal of family medicine and primary care2020
Vogt-Koyanagi-Harada (VKH) syndrome: A new perspective for healthcare professionals.
Review in Journal of family medicine and primary care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.
- Association of Alopecia Areata with Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.Dermatology (Basel, Switzerland) · 2023Pooled it
- Premature Ovarian Insufficiency in a Patient With Vogt-Koyanagi-Harada Syndrome: An Unusual Association-A Case Report.Case reports in medicine · 2026Article
- Article
- Steroid pulse therapy for VKH during pregnancy: a safe and effective option?Orphanet journal of rare diseases · 2025Review
- Vogt-Koyanagi-Harada Syndrome: A Case Report.Cureus · 2024Article
- [Vasculitis of the retina : Clinical aspects, diagnostics, management and treatment].Die Ophthalmologie · 2024Review
- Successive onset of Vogt-Koyanagi-Harada syndrome in father and son.BMC ophthalmology · 2023Article
- Vogt-Koyanagi-Harada syndrome in the setting of COVID-19 infection.Clinical case reports · 2023Article
- Outcome of Nivolumab-Induced Vogt-Koyanagi-Harada Disease-Like Uveitis in a Patient Managed without Intravenous Methylprednisolone Therapy.Case reports in ophthalmological medicine · 2023Article
- Bilateral Lupus Chorioretinopathy in a Patient With Active Systemic Lupus Erythematosus.Cureus · 2022Article
- Correlation between serum immunoglobulin levels and retinal structure in patients with newly diagnosed Vogt‑Koyanagi‑Harada disease.Molecular medicine reports · 2022Article
- Case of probable Vogt-Koyanagi-Harada syndrome: A rare presentation.Indian journal of ophthalmology · 2022Article
- Clinical Comparative Study of Different Fundus Imaging Methods in the Acute Phase of Vogt-Koyanagi-Harada Disease.Evidence-based complementary and alternative medicine : eCAM · 2022Article
- Vogt-Koyanagi-Harada patients show higher frequencies of circulating NKG2DClinical and experimental immunology · 2021Article
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders.Frontiers in immunology · 2020Article
- Vogt-Koyanagi-Harada Disease Following COVID-19 Infection.Case reports in ophthalmologyArticle
- Vogt-Koyanagi-Harada Syndrome from Dermatological Perspective: A Case Report.Indian dermatology online journalArticle
- Vogt-Koyanagi-Harada Syndrome - A Neurologist's Perspective.Annals of Indian Academy of NeurologyArticle
- A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy.Case reports in ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vogt-Koyanagi-Harada syndrome (VKH syndrome) is a rare granulomatous inflammatory disease that affects the melanin pigment producing melanocytes and mainly affects the pigmented structures such as eyes, ear, skin, meninges, and hair. VKT is an autoimmune disorder, which is mainly a T CD4+ Th1 lymphocyte-mediated aggression to melanocytes, in individuals with a genetic predisposition, in particular, the presence of HLA-DRB1 * 0405 allele. Melanin usually gives color to skin, hair, and eyes. Melanin is also found in the retina, where it plays a role in normal vision. This disease mainly leads to vision and hearing disturbances, followed by dermal problems. The most common symptoms include vitiligo, headaches, hair loss (alopecia), and hearing loss. This article describes the various signs and symptoms of VKH disease and its pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.